Lackner Mark (CIK 0001777413)

Latest company ownership

Role: Chief Scientific Officer
Shares held
124,714
Last filed at
Feb 5, 2025
Confidence Score
50.4
2025Q4
Confidence Score History
2024Q1 2025Q4
Role: SVP, Head of Biology
Shares held
596
Last filed at
Feb 10, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 3, 2025 Feb 5, 2025 Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Sell 91.3 +321,539 168.07% $24.6K
Jan 2, 2025 Jan 3, 2025 Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Sell 46.3 -4,411 -2.25% $13.8K
Feb 1, 2024 Feb 5, 2024 Zentalis Pharmaceuticals, Inc. Chief Scientific Officer Sell 91.3 +139,415 247.57% $18.3K
Feb 8, 2021 Feb 10, 2021 IDEAYA Biosciences, Inc. SVP, Head of Biology Sell 13.8 -2,000 -90.91% $42.1K
Jan 26, 2021 Jan 28, 2021 IDEAYA Biosciences, Inc. SVP, Head of Biology Sell 13.8 -2,501 -100.00% $46.2K
Jun 16, 2020 Jun 18, 2020 IDEAYA Biosciences, Inc. SVP, Head of Biology Sell 10.0 -7,123 -100.00% $108.2K
Jun 2, 2020 Jun 4, 2020 IDEAYA Biosciences, Inc. SVP, Head of Biology Sell 15.0 -845 -100.00% $7.8K